rs41285690

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_000110.4(DPYD):​c.*1062A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0112 in 152,260 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.011 ( 15 hom., cov: 33)
Failed GnomAD Quality Control

Consequence

DPYD
NM_000110.4 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.85

Publications

3 publications found
Variant links:
Genes affected
DPYD (HGNC:3012): (dihydropyrimidine dehydrogenase) The protein encoded by this gene is a pyrimidine catabolic enzyme and the initial and rate-limiting factor in the pathway of uracil and thymidine catabolism. Mutations in this gene result in dihydropyrimidine dehydrogenase deficiency, an error in pyrimidine metabolism associated with thymine-uraciluria and an increased risk of toxicity in cancer patients receiving 5-fluorouracil chemotherapy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]
DPYD Gene-Disease associations (from GenCC):
  • dihydropyrimidine dehydrogenase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0112 (1701/152260) while in subpopulation NFE AF = 0.0167 (1136/68018). AF 95% confidence interval is 0.0159. There are 15 homozygotes in GnomAd4. There are 762 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 15 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000110.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DPYD
NM_000110.4
MANE Select
c.*1062A>G
3_prime_UTR
Exon 23 of 23NP_000101.2Q12882-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DPYD
ENST00000370192.8
TSL:1 MANE Select
c.*1062A>G
3_prime_UTR
Exon 23 of 23ENSP00000359211.3Q12882-1
DPYD
ENST00000876340.1
c.*1062A>G
3_prime_UTR
Exon 24 of 24ENSP00000546399.1
DPYD
ENST00000969915.1
c.*1062A>G
3_prime_UTR
Exon 24 of 24ENSP00000639974.1

Frequencies

GnomAD3 genomes
AF:
0.0112
AC:
1702
AN:
152142
Hom.:
15
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00282
Gnomad AMI
AF:
0.0648
Gnomad AMR
AF:
0.00872
Gnomad ASJ
AF:
0.0294
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00311
Gnomad FIN
AF:
0.00961
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0167
Gnomad OTH
AF:
0.0139
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.0112
AC:
1701
AN:
152260
Hom.:
15
Cov.:
33
AF XY:
0.0102
AC XY:
762
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.00281
AC:
117
AN:
41570
American (AMR)
AF:
0.00871
AC:
133
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.0294
AC:
102
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.00332
AC:
16
AN:
4822
European-Finnish (FIN)
AF:
0.00961
AC:
102
AN:
10610
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0167
AC:
1136
AN:
68018
Other (OTH)
AF:
0.0137
AC:
29
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
86
173
259
346
432
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0138
Hom.:
20
Bravo
AF:
0.0109
Asia WGS
AF:
0.00116
AC:
4
AN:
3450

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Dihydropyrimidine dehydrogenase deficiency (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
8.8
DANN
Benign
0.84
PhyloP100
1.9
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41285690; hg19: chr1-97543470; API